Chris Schaumburg, Ph.D.

Scientific Advisory Board Member

Dr. Chris Schaumburg is an immunologist and business development leader with 15 years of cross-functional experience in scientific research, pharmaceutical drug discovery and development, and business development and strategy. Chris currently serves as Vice President of Corporate Affairs at Mirador Therapeutics in San Diego. Prior to Mirador, Dr. Schaumburg was VP of Pipeline Strategy at Prometheus Biosciences with transactional experience as former VP, Head of Business Development at Urovant Sciences. Dr. Schaumburg was also co-director of the Inflammation Research Program at Allergan, Inc. where he focused on drug discovery, development and strategy in the company’s largest therapeutic area. Chris holds a PhD from the University of California, Irvine and an MBA from UCLA Anderson School of Management.